Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Biopsychosocial Medicine|June 14, 2016
Oral cenesthopathyYojiro Umezaki, Anna Miura, Motoko Watanabe, et al.
Diagnostics (Basel, Switzerland)|June 2, 2021
Results of a Prospective Trial to Compare 68Ga-DOTA-TATE with SiPM-Based PET/CT vs. Conventional PET/CT in Patients with Neuroendocrine TumorsLucia Baratto, Akira Toriihara, Negin Hatami, et al.
World Journal of Radiology|September 21, 2016
Tumor characteristics of ductal carcinoma in situ of breast visualized on [F-18] fluorodeoxyglucose-positron emission tomography/computed tomography: Results from a retrospective studyTomoyuki Fujioka, Kazunori Kubota, Akira Toriihara, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 28, 2019
Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET/CT in patients with well-differentiated neuroendocrine tumorsAkira Toriihara, Lucia Baratto, Tomomi Nobashi, et al.
BMC Psychiatry|December 22, 2014
Oral Dysesthesia Rating Scale: a tool for assessing psychosomatic symptoms in oral regionsAkihito Uezato, Akira Toyofuku, Yojiro Umezaki, et al.
Medicine|April 13, 2021
A pilot study on EORTC or PERCIST for the prediction of progression-free survival with nivolumab therapy in advanced or metastatic gastric cancers: A STROBE-compliant articleMasatoyo Nakajo, Kazuhiro Kitajima, Akira Toriihara, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2019
18F-FPPRGD2 PET/CT in patients with metastatic renal cell cancerAkira Toriihara, Heying Duan, Holly M Thompson, et al.
Japanese Journal of Clinical Oncology|May 3, 2018
Clinical usefulness of 2-deoxy-2-[18F] fluoro-d-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0)Emi Yamaga, Akira Toriihara, Shin Nakamura, et al.
Annals of Biomedical Engineering|July 19, 2025
Automated Quantitative Evaluation of Age-Related Thymic Involution on Plain Chest CTYuki T Okamura, Katsuhiro Endo, Akira Toriihara, et al.
Clinical Nuclear Medicine|January 29, 2019
Predicting Response to Immunotherapy by Evaluating Tumors, Lymphoid Cell-Rich Organs, and Immune-Related Adverse Events Using FDG-PET/CTTomomi Nobashi, Lucia Baratto, Sunil A Reddy, et al.
Pageof 6